| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.100 | 28.642 | 41.391 | 35.390 | 19.590 | 20.218 | 13.965 | 14.412 | 9.602 | 5.810 |
| Total Income - EUR | 22.598 | 28.864 | 41.865 | 42.863 | 19.656 | 20.330 | 14.295 | 15.124 | 10.130 | 15.163 |
| Total Expenses - EUR | 11.548 | 15.612 | 18.057 | 15.536 | 15.640 | 16.702 | 17.694 | 20.004 | 20.510 | 22.106 |
| Gross Profit/Loss - EUR | 11.050 | 13.252 | 23.809 | 27.327 | 4.016 | 3.628 | -3.399 | -4.880 | -10.380 | -6.943 |
| Net Profit/Loss - EUR | 10.372 | 12.675 | 23.365 | 26.898 | 3.819 | 3.442 | -3.539 | -5.022 | -10.480 | -7.351 |
| Employees | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 1 |
Check the financial reports for the company - Hemimunologis S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.635 | 1.923 | 1.470 | 1.243 | 1.219 | 2.461 | 1.992 | 592 | 273 | 1.625 |
| Current Assets | 101.280 | 75.540 | 74.276 | 99.266 | 101.473 | 101.868 | 95.752 | 83.995 | 57.722 | 2.619 |
| Inventories | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 60.989 | 23.434 | 33.414 | 38.117 | 33.236 | 29.329 | 22.553 | 16.019 | 2.462 | 247 |
| Cash | 13.297 | 25.387 | 3.180 | 23.991 | 31.732 | 36.615 | 29.655 | 26.001 | 25.519 | 2.372 |
| Shareholders Funds | 100.234 | 75.145 | 73.558 | 99.106 | 101.007 | 102.534 | 96.721 | 83.483 | 56.514 | -1.411 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 2.680 | 2.317 | 2.188 | 1.402 | 1.685 | 1.795 | 1.023 | 1.104 | 1.481 | 5.655 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Hemimunologis S.r.l.